￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Exdensur (depemokimab-ulaa) is a medicine that treats what

2026-02-01 22:25:32

Check Details
How does Selumetinib/Coseyou exert its efficacy?

2026-02-01 22:25:32

Check Details
Lorlatinib/lorlatinib tablets drug price reference in 2026

2026-02-01 22:25:32

Check Details
Cabozantinib/nivolumab combination shows positive activity in FH-deficient renal cell carcinoma

2026-02-01 22:25:32

Check Details
What are the differences between domestically produced and imported Nintedanib, and which one to choose?

2026-02-01 22:25:32

Check Details
Exdensur (depemokimab-ulaa) instruction manual in Chinese

2026-02-01 22:25:32

Check Details
Which is the main manufacturer of Upatinib/Ruifu?

2026-02-01 22:25:32

Check Details
Bimetinib/Bemetinib belongs to which generation of targeted drugs

2026-02-01 22:25:32

Check Details
FDA Grants National Priority Certificate to Teritusumab Plus Daratumumab for the Treatment of Relapsed/Refractory Multiple Myeloma

2026-02-01 22:25:32

Check Details
Main functions and effects of Quizartinib

2026-02-01 22:25:32

Check Details
How effective is pomalidomide?

2026-02-01 22:25:32

Check Details
Exdensur (depemokimab-ulaa) effects and efficacy

2026-02-01 22:25:32

Check Details
Category
相关知识